| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 163.12B | 154.22B | 127.61B | 106.60B | 94.47B | 94.41B |
| Gross Profit | 103.50B | 98.59B | 84.00B | 70.74B | 61.51B | 62.67B |
| EBITDA | 10.84B | 10.16B | 9.32B | 6.58B | 7.23B | 1.54B |
| Net Income | 2.72B | 2.19B | 2.92B | 1.26B | 1.11B | -2.38B |
Balance Sheet | ||||||
| Total Assets | 106.69B | 104.16B | 91.12B | 79.70B | 76.96B | 74.55B |
| Cash, Cash Equivalents and Short-Term Investments | 15.93B | 16.87B | 19.12B | 14.88B | 13.39B | 13.69B |
| Total Debt | 39.37B | 35.37B | 26.59B | 21.12B | 20.37B | 22.39B |
| Total Liabilities | 60.78B | 58.54B | 47.25B | 38.29B | 36.36B | 34.42B |
| Stockholders Equity | 45.91B | 45.62B | 43.87B | 41.40B | 40.59B | 40.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.20B | 4.08B | 2.75B | 3.55B | -5.38B |
| Operating Cash Flow | 0.00 | 8.32B | 13.24B | 8.65B | 8.84B | 533.02M |
| Investing Cash Flow | 0.00 | -17.76B | -11.89B | -6.57B | -5.70B | -6.22B |
| Financing Cash Flow | 0.00 | 7.14B | 2.74B | -595.65M | -3.46B | 7.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥1.04T | 25.06 | 13.08% | 0.76% | 2.73% | 18.30% | |
63 Neutral | $749.16B | 45.71 | 9.53% | 0.55% | 15.58% | 60.90% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥133.44B | 31.47 | ― | 0.63% | 4.32% | 11.78% | |
57 Neutral | ¥113.73B | 15.35 | ― | 0.37% | 20.44% | 13.71% | |
53 Neutral | ¥379.15B | 34.66 | ― | 0.24% | 9.19% | 43.90% | |
53 Neutral | ¥206.48B | 72.52 | ― | 0.69% | 10.75% | -14.28% |